Cyclarity Therapeutics
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.cyclaritytx.comRevenue
$18.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cyclarity Therapeutics
Cyclarity Therapeutics develops innovative drugs aimed at preventing age-related diseases such as atherosclerosis, heart attacks, and strokes by targeting the underlying cause of arterial plaque build-up. Their technology focuses on removing non-degradable cholesterol from arterial walls, offering a novel approach to cardiovascular health. The company aims to provide simple and affordable preventive therapies, with a long-term goal of delivering disease-modifying treatments for various age-related conditions. Cyclarity's products are based on safe compounds and rationally designed molecules, reflecting a new perspective on treating cardiovascular diseases.Explore more
Cyclarity Therapeutics Org Chart
NR
Head of Clinical Affairs
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cyclarity Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cyclarity Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Cyclarity Therapeutics
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cyclarity Therapeutics launches new products
Funding: Get notified immidiatlly once Cyclarity Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cyclarity Therapeutics is spiking on competitors!
Click to see if Cyclarity Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Cyclarity Therapeutics recently announced quarterly report
Check if Cyclarity Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cyclarity Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Cyclarity Therapeutics
Compare insights from companies similar to Cyclarity Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cyclarity Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cyclarity Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cyclarity Therapeutics.
Cyclarity Therapeutics Tech Stack
Cyclarity Therapeutics News & Media
Cyclarity Therapeutics Secures Approval for First-in-Human Clinical Trial
NOVATO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX, one of Australia’s leading clinical research centers, in partnership with Monash University. This effort will be led by Dr. Stephen Nicholls of the Victorian Heart Institute (VHI), a distinguished leader in cardiovascular medicine. In addition to a traditional SAD/MAD phase 1 trial, the authorization i
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cyclarity Therapeutics
Sign Up For FreeTo access detailed company insights
Cyclarity Therapeutics develops innovative drugs aimed at preventing age-related diseases such as atherosclerosis, heart attacks, and strokes by targeting the underlying cause of arterial plaque build-up. Their technology focuses on removing non-degradable cholesterol from arterial walls, offering a novel approach to cardiovascular health. The comp... Read More
